• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Homologous Wasting Disease

Homologous Wasting Disease - 12 Studies Found

Completed : Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease
: Graft Versus Host Disease
: 2002-03-08
:
  • Drug: cyclosporine
  • Drug: hydroxychloroquin

Completed : Compassionate Use of Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Gastrointestinal Tract
: Graft Versus Host Disease
: 2003-03-06
: Drug: beclomethasone dipropionate
Not yet recruiting : A Study of Obinutuzumab for Prevention of Chronic Graft-vs.-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation
: Graft vs. Host Disease
: 2016-08-11
:
  • Drug: Obinutuzumab B cell depl

Completed : Beclomethasone Plus Prednisone in Treating Patients With Graft-Versus-Host Disease
: Graft Versus Host Disease
: 2002-08-05
:
  • Drug: beclomethasone dipropionate
  • Drug: me

Completed : Prevention of Ocular Graft-Versus-Host Disease With Topical Cyclosporine in Recipients of Allogeneic HSCT
: Graft-Versus-Host Disease
: 2014-05-13
: Drug: Cyclosporine Use of topical cyclosporine (one drop of cyclosporine in each eye, twice a day for 12
Terminated : A Study of Rituximab Combined With Prednisone for the Initial Treatment of Chronic Graft Versus Host Disease (cGVHD)
: Graft Versus Host Disease
: 2010-02-08
: Drug: Rituximab Rituximab 375 mg/m2 IV weekly X 4 doses + Prednisone 1 mg/kg/d
Completed : Safety and Efficacy Study of Photopheresis With UVADEX to Prevent Graft-versus-Host Disease
: Graft-versus-Host Disease
: 2003-02-05
:
  • Drug: Methoxsalen
  • Procedure: Extracorporea

Completed : Safety and Efficacy Study of Photopheresis Plus Standard Therapy to Treat Chronic Graft-versus-Host Disease
: Graft-versus-Host Disease
: 2003-02-05
:
  • Drug: Methoxsalen
  • Procedure: Extracorporea

Terminated : Alefacept for Prevention of Graft Versus Host Disease (GVHD)
: Graft Versus Host Disease
: 2006-07-31
:
  • Drug: Alefacept (AMEVIVE®)

Recruiting : Mesenchymal Stem Cells as a Treatment for Oral Complications of Graft-versus-host Disease
: Graft -Versus-host-disease
: 2014-02-04
: Biological: Mesenchymal stromal cells Allogenous mesenchymal stromal cells will be injected directly und
Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.